Abstract
Essential thrombocythemia (ET) is a chronic myelo-proliferative disorder typical of middle age. However, it has also been observed in children and young adults.1–2 Major thrombotic episodes and microvascular disturbances have been described in young ET patients, but the real risk for vascular complications has not been clearly established, and specific therapeutic approaches have been investigated.3–7 In this study, we retrospectively analyzed a cohort of 76 thrombocytemic patients, younger than 40 years at diagnosis, with the following aims: (1) to evaluate thrombotic and hemorrhagic complications; (2) to specify the treatment adopted; and (3) to report pregnancy outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
